Measuring the return from pharmaceutical innovation 2014

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.


Medical Technology M&A

A look at medical technology macro trends and how they are making M&A more attractive than in recent years. 

Homi Kapadia

US Life Sciences Sector Leader

Homi, Vice Chairman at Deloitte LLP, has 30 years of experience with life sciences, consumer business, and process industry clients. As the National Life Sciences Leader, he leads Deloitte's life sciences practice that provides audit, consulting, enterprise risk, financial advisory, and tax services to pharmaceutical, biotechnology, medical technology, and consumer health care clients. Homi has also served on the Board of Directors for Deloitte LLP and the Consulting Executive Committee.

Connect via email


Submit RFP

Submit via our online form

Find an office

Find a local office


Matthew Hudes

Principal | BioPharma Segment Leader


Glenn Snyder

Medical Technology Segment Leader